Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
1.230
0.00 (0.00%)
At close: Jun 23, 2026, 4:00 PM EDT
1.276
+0.046 (3.74%)
Pre-market: Jun 24, 2026, 4:00 AM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $88.93 million as of June 24, 2026. Its market cap has decreased by -4.95% in one year.
Market Cap
88.93M
Enterprise Value
45.47M
1-Year Change
-4.95%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $88.93M, a decrease of -81.82%. That is a compound annual growth rate of -28.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 88.93M | 1.43% |
| Dec 31, 2025 | 87.67M | -37.65% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 91.32M |
| Alterity Therapeutics | 89.96M |
| Aardvark Therapeutics | 89.01M |
| Cardiff Oncology | 88.88M |
| NeurAxis | 88.67M |
| ImmuCell | 88.16M |
| Telomir Pharmaceuticals | 88.03M |
| Lixte Biotechnology Holdings | 86.90M |